Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Biopsy Devices Market Research Report Information By Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles [Vacuum-Assisted Biopsy (VAB) Devices, Fine Needle Aspiration Biopsy (FNAB) Devices, Core Needle Biopsy (CNB) Devices], Biopsy Forceps, Localization Wires, and Others), By Application (Breast Biopsy, Prostate Biopsy, Liver Biopsy, Lung Biopsy, Gynecological Biopsy, and Others), By Guidance Technique (Ultrasound-Guided Biopsy, Stereotactic Guided Biopsy, MRI-Guided Biopsy, CT Guided Biopsy, and Others), By End User (Hospital


ID: MRFR/MED/1652-CR | 80 Pages | Author: Rahul Gotadki| March 2023

Global Biopsy Devices Market Overview


The Biopsy Devices Market Size was valued at USD 2.64 billion in 2023 and is projected to grow from USD 2.81 billion in 2024 to USD 4.4 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 5.72% during the forecast period (2024 - 2032). The increasing prevalence of cancer and increasing preference for minimally invasive surgeries are driving the market growth.


Biopsy Devices Market


  Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Biopsy Devices Market Trends


Rising prevalence of cancer to boost market growth


A biopsy is a type of diagnostic procedure used to find both malignant and non-cancerous abnormalities in the human body. The global market for biopsy devices is projected to expand due to the rising incidence of cancer in the population. For instance, cancer is the second-leading cause of death in the US after heart disease and is the primary cause of death in Canada. According to the American Cancer Society, there were 693,000 cancer fatalities and 1.9 million new cancer diagnoses in 2018. In North America, prostate cancer is the disease that is most frequently diagnosed in men, but breast cancer continues to be the most common cancer in women. Lung cancer continues to be the leading cause of death in both sexes. One of the main causes of the population's cancer incidences rising is the rapid change in lifestyle, as well as the intake of alcohol and cigarette products. Boston Scientific Corporation, BD, Qiagen, F. Hoffman La-Roche Ltd., Hologic, and other significant manufacturers of biopsy instruments and related products for the diagnosis of cancer and other disorders. Hence, it is anticipated that the global market for biopsy instruments will expand due to the rising incidence of cancer worldwide.


Biopsy Devices Market Product Type Insights


Biopsy Devices Product Type Insights


The Market segments of Biopsy Devices, based on product type, includes biopsy guns, biopsy guidance system, biopsy needles, biopsy forceps, localization wires, and others. The biopsy guns segment accounted for the largest share in 2022 and the biopsy needle segment is anticipated to be the fastest growing for the forecast period 2023-2030. Over the forecast period, a surge in demand for these weapons to collect samples from internal organs' soft tissues, such as kidneys, breasts, and lungs, is anticipated to support the market's overall expansion. One of the main elements supporting the segment's growth is the increasing demand for quick and delicate cell sample collection for biopsies.


Figure 2: Biopsy Devices Market, by Product Type, 2023 & 2030 (USD Billion)Biopsy Devices Market, by Product Type, 2022 & 2030


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


Biopsy Devices Application Insights


Based on application, the global Biopsy Devices industry has been segmented into breast biopsy, prostate biopsy, liver biopsy, lung biopsy, gynecological biopsy, and others. The breast biopsy segment accounted for the largest share in 2022 and is anticipated to be the fastest growing for the forecast period 2023-2030. This is due to the rise in breast cancer cases that has been seen over the years and is predicted to continue in the coming years. At the moment, breast cancer can be detected effectively and quickly using modern biopsy tools. The demand for the usage of biopsy equipment has increased globally due to increased public awareness of disease screening and technological advancements in biopsy devices.


May 2021 Hologic announced the launch of the Brevera Breast Biopsy System with CorLumina Imaging Technology in Japan. The system allows for real-time imaging and biopsy sample collection in a single system, reducing the need for multiple devices during the biopsy procedure.


Biopsy Devices Guidance Technique Insights


Based on guidance technique, the global market of biopsy devices has been categorized into ultrasound-guided biopsy, stereotactic guided biopsy, MRI-guided biopsy, CT guided biopsy, and others. The CT guided biopsy segment accounted for the largest share in 2022 and is anticipated to be the fastest growing for the forecast period 2023-2030. The market for ultrasound-guided biopsies is anticipated to grow at the highest CAGR during the forecast period due to the growing use of this technique for cancer detection in diagnostic laboratories as well as its many advantages and diverse applications. These advantages include high throughput, high efficiency, accuracy, and minimal invasiveness, all of which are anticipated to fuel this segment's market expansion.


Biopsy End User Insights


Based on end user, the global market biopsy devices has been categorized into hospitals & clinics, diagnostic & imaging centers, academic & research institutes, and others. The hospitals & clinics segment accounted for the largest share in 2022 and is anticipated to be the fastest growing for the forecast period 2023-2030. Due to the wide availability of cutting-edge medical equipment and reimbursement policies, the hospitals & clinics market segment controlled over 68% of the global market share for biopsy instruments. The National Average Medicare rate for breast biopsy operations with the implantation of a breast localization device in hospitals was around USD 1,400 in 2021, according to the coding and reimbursement guide from Hologic. The number of surgical procedures performed in hospitals will increase as a result of these variables, which will increase the use of biopsy medical equipment.


Biopsy Devices Regional Insights


By Region, the study segments the market into North America, Europe, Asia-Pacific, and the Rest of the World. The growth of the North America Biopsy Devices market is attributed to the high market penetration rates of cutting-edge products, like vacuum-assisted biopsy systems, and a quickly rising market demand for disposable products.


Further, the major countries studied are: the U.S., Canada, Germany, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.


Figure 3: BIOPSY DEVICES MARKET SIZE BY REGION 2023 & 2030 (USD Billion)BIOPSY DEVICES MARKET SIZE BY REGION 2022 & 2030


Source: Secondary Research, Primary Research, MRFR Database and Analyst Review


North America Biopsy Devices market accounts for the largest market share due to the presence of well-established market players in the nation, high market penetration rates of cutting-edge products, like vacuum-assisted biopsy systems, and a quickly rising market demand for disposable products. Furthermore, the US market of Biopsy Devices held the largest market share and the Canada market of Biopsy Devices accounted for the second largest market in North America. The inclination for minimally invasive procedures, an increase in cancer incidence globally, and government initiatives for diagnosis in this region are the driving forces behind the growth of the biopsy instruments market.


The Asia-Pacific Biopsy Devices Market is expected to grow at the highest rate from 2023 to 2030. This is due to the rising incidence of cancer, the big populations in nations like China and India, the improved healthcare infrastructure, increased healthcare spending and government initiatives, and the increasing attention of major market participants in the region are all contributing to the segment's rise. Moreover, the China market of Biopsy Devices held the largest market share, and the Japan market of Biopsy Devices was the fastest-growing market in the Asia-Pacific region.


Biopsy Devices Key Market Players & Competitive Insights


Many global, regional, and local vendors characterize the biopsy device market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality polyamide products to survive and succeed in an intensely competitive market.


The market vendors’ growth depends on market conditions, government support, and industry development. Thus, the vendors should focus on expanding geographically and improving services. Argon Medical Devices (US), BD (US), Cook Medical (US), CONMED Corporation (US), Olympus Corporation (Japan), Hologic, Inc. (US), Cardinal Health Inc. (US), Integra LifeSciences (US), Medtronic plc (US), Mammotome (US), INRAD (US), and Trivitron Healthcare (India) are the major companies in the market that compete in terms of availability, quality, price, and technology. They primarily focus on the development of biopsy device products. Although international players dominate the market, regional and foreign players with small market shares also have a presence. The international players may strengthen their presence worldwide through acquisitions during the forecast period.


Argon Medical Devices (US) is a global medical technology company that specializes in the development, manufacturing, and marketing of medical devices for interventional procedures. The company has a strong focus on providing innovative, high-quality products to healthcare professionals, and improving patient care. Argon Medical Devices offers a wide range of products, including vascular access devices, biopsy and drainage devices, and peripheral vascular devices.


Key Companies in the market of Biopsy Devices include



  • Argon Medical Devices (US)

  • BD (US)

  • Cook Medical (US)

  • CONMED Corporation (US)

  • Olympus Corporation (Japan)

  • Hologic, Inc. (US)

  • Cardinal Health Inc. (US)

  • Integra LifeSciences (US)

  • Medtronic plc (US)

  • Mammotome (US)

  • INRAD (US)

  • Trivitron Healthcare (India) among others


Biopsy Devices Industry Developments


March 2022 Trivitron Healthcare, a global medical technology company, has acquired a 100% stake in The Kennedy Company (US), a leading manufacturer of radiation protection X-ray shielding material and acoustic barrier products. This will help Trivitron to serve acquired companies’ clients with Breast Biopsy products in the US.


September 2021 Olympus Corporation launched EZ Shot 3 Plus 25 G needle in September 2021. The EZ Shot 3 Plus is a fine needle biopsy device that is designed to obtain high-quality tissue samples with minimal damage to surrounding tissue.


January 2020 BD acquired Straub Medical AG (Switzerland) which develops and manufactures biopsy systems. This acquisition expands BD's portfolio of breast biopsy products and strengthens its position in the market.


Biopsy Devices Market Segmentation


Biopsy Devices Product Type Outlook



  • Biopsy Guns

  • Biopsy Guidance System

  • Biopsy Needles

    • Vacuum-Assisted Biopsy (VAB) Devices

    • Fine Needle Aspiration Biopsy (FNAB) Devices

    • Core Needle Biopsy (CNB) Devices



  • Biopsy Forceps

  • Localization Wires

  • Others


Biopsy Devices Application Outlook



  • Breast Biopsy

  • Prostate Biopsy

  • Liver Biopsy

  • Lung Biopsy

  • Gynecological Biopsy

  • Others


Biopsy Devices Guidance Technique Outlook



  • Ultrasound-Guided Biopsy

  • Stereotactic Guided Biopsy

  • MRI-Guided Biopsy

  • CT Guided Biopsy

  • Others


Biopsy Devices End User Outlook



  • Hospitals & Clinics

  • Diagnostic & Imaging Centers

  • Academic & Research Institutes

  • Others


Biopsy Devices Regional Outlook



  • North America

    • US

    • Canada



  • Europe

    • Germany

    • France

    • UK

    • Italy

    • Spain

    • Rest of Europe



  • Asia-Pacific

    • China

    • Japan

    • India

    • Australia

    • South Korea

    • Australia

    • Rest of Asia-Pacific



  • Rest of the World

    • Middle East

    • Africa

    • Latin America



Report Attribute/Metric Details
Market Size 2023 USD 2.64 billion
Market Size 2024 USD 2.81 billion
Market Size 2032 USD 4.4 billion
Compound Annual Growth Rate (CAGR) 5.72% (2024-2032)
Base Year 2023
Forecast Period 2024-2032
Historical Data 2019 to 2021
Forecast Units Value (USD Billion)
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Product Type, Application, Guidance Technique, End User, and Region
Geographies Covered North America, Europe, Asia Pacific, and the Rest of the World
Countries Covered The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil
Key Companies Profiled Argon Medical Devices (US), BD (US), Cook Medical (US), CONMED Corporation (US), Olympus Corporation (Japan), Hologic, Inc. (US), Cardinal Health Inc. (US), Integra LifeSciences (US), Medtronic plc (US), Mammotome (US), INRAD (US) and Trivitron Healthcare (India)
Key Market Opportunities 路聽聽聽聽聽聽聽聽 Adoption of robotic assisted biopsy systems 路聽聽聽聽聽聽聽聽 Approval and launch of new products by key players
Key Market Dynamics 路聽聽聽聽聽聽聽聽 Rising prevalence of cancer 路聽聽聽聽聽聽聽聽 Increasing preference for minimally invasive surgeries 路聽聽聽聽聽聽聽聽 Rise in government initiatives


Frequently Asked Questions (FAQ) :

The Biopsy Devices Market is anticipated to reach USD 4.4 billion at a CAGR of 5.72% during the forecast period of 2024 to 2032

The Biopsy Devices Market is expected to register a CAGR of 5.72% during the forecast period of 2024 to 2032.

Argon Medical Devices (US), BD (US), Cook Medical (US), CONMED Corporation (US), Olympus Corporation (Japan), Hologic, Inc. (US), Cardinal Health Inc. (US), Integra LifeSciences (US), Medtronic plc (US), Mammotome (US), INRAD (US) and Trivitron Healthcare (India)

The biopsy guns segment held the majority share in 2022 contributing to around 37.26% with respect to the Biopsy Devices Market

Breast biopsy segment dominated the market in 2022

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.